搜期刊

Expert Opinion on Emerging Drugs PubMed AJ SCIE JCR:Q2 中科院3区
发文量 914
被引量 16,367
影响因子(2023) 2.492

Expert Opinion on Emerging Drugs [ISSN 1472-8214]; [e-ISSN 1744-7623] is a MEDLINE-indexed, international journal publishing rigorously peer-reviewed review articles and original papers on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.Each article is structured to incorporate the author’s own expert opinion on the impact of the topic on research and clinical practice and the scope for future development.

  • 主办单位: TAYLOR & FRANCIS LTD
  • 出版地区: United Kingdom
  • 出版周期: 年4期
  • 别名: 新兴药物专家意见
  • 国际标准连续出版物号: ISSN 1472-8214
  • 创刊时间: 1996年
  • 曾用名: Emerging Drugs (1996 - 2001)
收录汇总 栏目浏览 期刊详情
收录汇总
出版文献
期刊详情
分析评价
  • 1
  • 2
  • 3
目录
封面
2002年01期
共:14篇

      不详

    • Uzan, Andre

      1-2
    • Arikan, SevtapRex, John H.

      3-32
    • Ruijgrok, Elisabeth J.Meis, Jaques F.G.M.

      33-45
    • Rothstein, David M.Helmerhorst, Eva J.Spacciapoli, PeterOppenheim, Frank G.Friden, Phillip

      47-59
    • Olliaro, PieroLazdins, JanisGuhl, Felipe

      61-67
    • Gniadecki, RobertCalverley, Martin J.

      69-90
    • Talley, Nicholas J.

      91-98
    • Minamino, TetsuoKitakaze, Masafumi

      99-110
    • Iqbal, OmerMessmore, HarryFareed, JawedAhmad, SarfrazHoppensteadt, DebraShadid, HazarTobu, MahmutAziz, SalimWehrmacher, William

      111-139
    • Clark, Abbot F.Pang, Iok-Hou

      141-163
    • Perry, Colin G.Petrie, John R.

      165-174
    • Osuji, NnennaPettengell, R.

      175-188
    • Olgaard, KlausLewin, Ewa

      189-199
2002年01期

2002年01期